Biomarkers & Precision Medicine USA Congress

Biomarkers & Precision Medicine USA Congress
 3-4 October 2016, San Diego, USA

 

Oxford Global Conferences are proud to present the Biomarkers & Precision Medicine USA Congress, taking place on the 3-4 October 2016 in San Diego, USA.

 

The congress will bring together over 250 delegates representing leading biotech companies, global pharma organisations and internationally renowned academic institutions. The congress will cover over 40 presentations, case studies and panel discussions focused on the key issues in biomarker research, companion diagnostics, personalised medicine and clinical biomarkers,.

 

The Congress will cover 5 Interactive Streams:

 

 • Biomarkers in Drug Discovery and Development – Translation and Precision Medicine in Auto-Immune Diseases, CNS, Oncology, and Infectious Diseases

 • Personalised Medicine, Companion Diagnostics & Patient Testing

 • Innovations In Biomarker Research – Informatics, Data Management, Assay Development, Imaging Technologies

 • Biomarker in Clinical Development & Clinical Trials

 • Clinical Diagnostics, NGS & Genomic Markers and Genetic Testing

 

Biomarkers Congress offers 14 pre-scheduled one to one meetings, exhibition and informal networking opportunities.

 

Attended by over 200 participants from the pharmaceutical industry, the congress offers a balance of scientific presentations and unprecedented networking opportunities. In line with the current industry trends, expert case studies will also cover insights into novel biomarker discoveries and development in different therapeutic areas such as immune-oncology, CNS diseases, neuroscience & infectious diseases.

 

Building on the success of previous Biomarker events, the Biomarkers & Precision Medicine USA Congress has a featured focus in the role of Biomarkers in Clinical Development. This highlights the role of biomarkers in clinical development, clinical trials and clinical diagnostics. Industry leaders will discuss the ever increasing role of NGS & genomic markers in clinical diagnostics & decision making. Hear the latest case studies on the use of microRNA’s, CTCs and free circulating RNA & DNA as biomarkers in clinical diagnostics.

 

Over the course of 2 days, our renowned speaker panel will discuss the following topics:

 

 • Overcoming challenges of clinical validation & translation

 • Surrogate endpoints: utilising biomarkers in clinical trials

 • Implementing biomarker data into clinical development strategies

 • Transforming clinical development through biomarker driven clinical trials design

 • Predictive biomarker discovery in proof – of concept clinical studies

 • NGS for clinical testing & diagnostics

 • Case Studies: mircoRNA’s, CTCs, circulating free DNA & exosomes

 • Biomarkers for non-invasive diagnosis

 • The importance of liquid biopsy’s

 • Clinical effectiveness of diagnostic & screening of new markers

 

See the Agenda now: http://www.biomarkersusa-congress.com/download-agenda/

 

For further information please contact  g.alonso@oxfordglobal.co.uk or +44 7508 803133 / +44(0) 1865 248455